Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.62 |
| ▸ | HTR6 | P50406 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | MPO | P05164 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
| ▸ | CA2 | P00918 | 4/20 | 0.59 |
| ▸ | CA9 | Q16790 | 4/20 | 0.59 |
| ▸ | CA1 | P00915 | 3/20 | 0.59 |
| ▸ | CA12 | O43570 | 3/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.59 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.59 |
| ▸ | AGO2 | Q9UKV8 | 2/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.59 |
| ▸ | CA4 | P22748 | 1/20 | 0.59 |
| ▸ | CA6 | P23280 | 1/20 | 0.59 |
| ▸ | CA5A | P35218 | 1/20 | 0.59 |
| ▸ | CA7 | P43166 | 1/20 | 0.59 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.59 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2235344 | 0.97 | TSHR (0.59) | TSHRHTR6LMNAMPOCYP3A4 | |
| Acetaldehyde SCHEMBL4349619 | 0.89 | TSHR (0.50) | TSHRHTR6LMNAMPOCYP3A4 | |
| SCHEMBL14610271 | 0.87 | GFER (0.58) | TSHRHTR6LMNAMPOCYP3A4 | |
| Dapsone SCHEMBL11375057 | 0.87 | HTR6 (0.67) | TSHRHTR6LMNAMPOCYP3A4 | |
| SCHEMBL651902 | 0.85 | ALDH1A1 (0.71) | TSHRHTR6LMNAMPOCYP3A4 | |
| Sulfanilamide SCHEMBL29080914 | 0.79 | CA2 (0.85) | TSHRHTR6LMNAMPOCYP3A4 | |
| SCHEMBL2367293 | 0.78 | CA2 (0.64) | TSHRCA2CA9CA1CA12 | |
| SCHEMBL27446604 | 0.77 | TSHR (0.86) | TSHRHTR6LMNAMPOCYP3A4 | |
| SCHEMBL948147 | 0.77 | ALDH1A1 (0.46) | TSHRHTR6LMNAMPOCYP3A4 | |
| SCHEMBL324893 | 0.77 | HTR6 (1.00) | TSHRHTR6LMNAMPOCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250107976-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | L'OREAL (FR) | 2025-04-03 | — | — | US | claimed |
| WO-2025072691-A1 | COMPOSITIONS AND METHODS FOR TREATING HAIR | HART TAYLOR (US) | 2025-04-03 | — | — | WO | claimed |
| CN-119241399-A | Benzenesulfonyl compound taking AR/AR-V7 double protein as target point and preparation method and application thereof | 上海应用技术大学 | 2025-01-03 | — | — | CN | claimed |
| WO-2024205303-A1 | NOVEL AMIDE-BASED COMPOUND AND COMPOSITION COMPRISING SAME | (주)아모레퍼시픽 | 2024-10-03 | — | — | WO | claimed |
| CN-118028896-A | Production method of alkaline electrolyzed water hydrogen production diaphragm | 湖北氢益氢能科技有限公司 | 2024-05-14 | — | — | CN | claimed |
| CN-117126695-B | Preparation method of degradable lubricating oil | 广州市蔚森节能科技有限公司 | 2024-01-30 | — | — | CN | claimed |
| CN-117126695-A | Preparation method of degradable lubricating oil | 广州市蔚森节能科技有限公司 | 2023-11-28 | — | — | CN | claimed |
| US-20230301892-A1 | COMPOSITIONS AND METHODS FOR ELONGATING CURLY HAIR | L'OREAL (FR) | 2023-09-28 | — | — | US | claimed |
| WO-2023154471-A2 | COMPOSITIONS AND METHODS FOR STYLING HAIR | LAGA STEPHANIE (US) | 2023-08-17 | — | — | WO | claimed |
| US-20230248629-A1 | COMPOSITIONS AND METHODS FOR STYLING HAIR | L'OREAL (FR) | 2023-08-10 | — | — | US | claimed |
| US-20190201309-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | L'OREAL (FR) | 2019-07-04 | — | — | US | claimed |
| US-9556342-B2 | Zwitterionic lignin derivatives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2017-01-31 | — | — | US | claimed |
| CN-104678028-A | Pretreatment and detection method for biogen amine neurotransmitter and detection kit | INST PHARM & TOXICOLOGY AMMS | 2015-06-03 | — | — | CN | claimed |
| US-20150135989-A1 | ZWITTERIONIC LIGNIN DERIVATIVES | CRESTLINE DIRECT FINANCE, L.P. | 2015-05-21 | — | — | US | claimed |
| EP-2528923-B1 | PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES | MAPI PHARMA LTD (IL) | 2014-07-30 | — | — | EP | claimed |
| EP-2528923-A1 | PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES | Mapi Pharma Limited (IL) | 2012-12-05 | — | — | EP | claimed |
| CN-102725295-A | Process for the preparation of darunavir and darunavir intermediates | MAPI PHARMA HK LTD | 2012-10-10 | — | — | CN | claimed |
| WO-2011092687-A1 | PROCESS FOR THE PREPARATION OF DARUNAVIR AND DARUNAVIR INTERMEDIATES | MAPI PHARMA HK LIMITED (CN) | 2011-08-04 | — | — | WO | claimed |
| EP-2120555-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | Heller, Adam (US) | 2009-11-25 | — | — | EP | claimed |
| WO-2008094664-A1 | METHODS AND COMPOSITIONS FOR THE TREATMENT OF PAIN | HELLER ADAM (US) | 2008-08-07 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230248629-A1 | COMPOSITIONS AND METHODS FOR STYLING HAIR | DPM1, NACA, FUT6 | TSHR 4465/4885HTR6 720/4885LMNA 2855/4885 |
| US-20190201309-A1 | COMPOSITIONS FOR ALTERING THE COLOR OF HAIR | TYR, SHH, AADAT | TSHR 3883/4885HTR6 1440/4885LMNA 1513/4885 |
| US-20230301892-A1 | COMPOSITIONS AND METHODS FOR ELONGATING CURLY HAIR | GLUL, NACA, SHH | TSHR 4654/4885HTR6 1122/4885LMNA 2888/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.